[M(arene)(HQ)Cl] complexes (M = RuII/OsII/RhIII/IrIII; HQ = 8-hydroxyquinoline) have shown promise as anticancer agents. To assess the effect of conjugating biotin (vitamin B7) to such compounds and improve their tumor-targeting ability through interaction with the sodium-dependent multivitamin transporter (SMVT), the chlorido co-ligand was exchanged with biotinylated 6-aminoindazole. The complexes were characterized by NMR spectroscopy and mass spectrometry, and purity was determined by elemental analysis. The compounds were shown to be stable in aqueous solution but reacted in particular with biologically relevant nitrogen-donor ligands. The biotinylated organometallics were shown to be able to interact with the high-affinity biotin-binding protein streptavidin using molecular modelling. High antiproliferative activity of the biotinylated Rh complex (IC50 = 1.1–10 μM) and its chlorido precursor (IC50 = 2.1–7.0 μM) was demonstrated in human HCT116, NCI-H460, COLO 205, SW620, A2780 and A2780cis cancer cells, which feature differing levels of SMVT expression. While there was no clear relationship between the anticancer activity in cells and SMVT expression, the complexes showed similar activity in cisplatin-sensitive and -resistant cells. The most potent was the biotinylated Rh derivative which displayed low toxicity toward zebrafish embryos with >75% survival up to day 4 and after treatment with up to 32 μM complex.
Some half-sandwich compounds with a variety of ligands and metal centres have shown promising anticancer activity. Herein we report a series of reactions between the sulfonylthiourea ligands p-TolSO2NHC(S)NHPh, EtSO2NHC(S)NHPh and CH3SO2NHC(S)NHPh and [(η6-p-cymene)RuCl2]2, [(η6-arene)RuCl2(PR3)] (arene = benzene or p-cymene), [Cp*MCl2(PR3)] or [Cp*RhCl2]2 (M = Ir(III), Rh(III)), Cp* = η5-pentamethylcyclopentadienyl, PR3 = triphenylphosphine (PPh3), tris(2-cyanoethyl)phosphine (tcep) and 1,3,5-triaza-7-phosphaadamantane (pta) and their corresponding piano stool complexes. Single crystal X-ray diffraction structure determinations indicated that the resulting linkage isomer of the complex, i.e., proximal (coordination via S,N(sulfonated) placing the sulfonyl group near the coordination sphere) or distal (coordination via S,N(non-sulfonated), placing the sulfonyl group away from the coordination sphere), is directly related to the steric bulk around the metal centre. Proximal to distal isomerisation of the complex [(η6-p-cymene)Ru{p-TolSO2NC(S)N(PPh3)}] (1aL1) was observed by 1H and 31P{1H} NMR spectroscopy. DFT calculations suggested this to be the result of the conversion from the initially formed kinetically favourable to the thermodynamically favourable isomer. Computational investigation of non-covalent interactions using the reduced density gradient also revealed a chalcogen bond present between the thiourea sulfur and sulfonyl oxygen atoms of complex 1aLa. The in vitro antiproliferative activity of several complexes was determined against human cancer cells, which revealed a correlation between potency and lipophilic properties of the ancillary ligands for a series of Ru(II) p-cymene complexes.
SAHA (vorinostat) is a clinically used pan-HDAC inhibitor, making SAHA-derived scaffolds attractive for multifunctional designs that combine HDAC modulation with additional cytotoxic mechanisms. Here, we replaced the SAHA cap group with an 8-hydroxyquinoline (8-HQ) chelator to generate a hydroxamate ligand (L1) and a series of Ru(II), Os(II), Ir(III), and Rh(III) half-sandwich complexes. L1 potently inhibited HDACs in vitro, while metal coordination generally attenuated HDAC inhibitory activity. In cells, L1 and selected complexes increased α-tubulin acetylation and elevated histone H3 acetylation at higher concentrations, consistent with broader HDAC engagement. The compounds showed moderate to high antiproliferative activity across multiple human cancer cell lines and low resistance factors in cisplatin-resistant models.Notably, the ester analogue L2 was inactive against HDACs in vitro yet retained antiproliferative activity, suggesting an HDACindependent contribution consistent with the 8-HQ pharmacophore and its metal-tunable reactivity. Among the complexes, the Rh(Cp*) derivative retained strong antiproliferative potency, highlighting the multifunctional nature of this platform.